NCT00352105View on ClinicalTrials.gov

Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

May 31, 2010

Conditions
Head and Neck Cancer
Interventions
DRUG

cisplatin

20mg/m2/d IV continuous infusion x4 days

DRUG

fluorouracil

1000mg.m2/d IV continuous x 4 days

DRUG

Iressa

250mg/PO qd x 2 years

RADIATION

hyperfractionated radiation therapy

120cGy bid

Trial Locations (1)

44195

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

David Adelstein

OTHER

NCT00352105 - Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer | Biotech Hunter | Biotech Hunter